HOME >> BIOLOGY >> NEWS
Hypertension in African Americans linked to two genomic regions

St. Louis, Feb. 9, 2005 -- A first-of-its-kind application of a novel statistical method of analysis to African Americans has identified regions on chromosomes 6 and 21 that likely harbor genes contributing to high blood pressure in that group. The novel statistical method, called admixture mapping, narrowed the search for genes related to hypertension, bringing researchers and doctors closer to finding more effective treatments.

Researchers at Stanford University School of Medicine, Loyola University Medical Center and Washington University School of Medicine in St. Louis, among others, collaboratively conducted the study, which will be published in the February issue of Nature Genetics and is available online.

In the U.S., 65 million people have high blood pressure, but it is found more often in African Americans than other groups. African Americans suffer from earlier and more severe hypertension and have a higher rate of death from stroke, heart disease, and kidney failure as a result.

The causes of hypertension are complex. Diet, exercise and stress contribute, but so do genetic factors. "It wouldn't be surprising if hypertension involved dozens of genes," says Dabeeru C. Rao, Ph.D., director of the Division of Biostatistics and one of the report's authors. "Unfortunately, in the past there have been conflicting reports about genes linked to the condition."

In a fresh approach to the problem, the researchers applied a genome-wide scan that compared how often genetic variations occur in people of African or European descent to how often they occur in African Americans.

As a group, African Americans can trace their ancestry largely to populations from both Africa and Europe. "The statistical technique we used is ideal for groups who have a trait with a higher occurrence--such as hypertension in African Americans--and who stem from two sets of ancestral populations that have differing genetic variations," Rao s
'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
9-Feb-2005


Page: 1 2 3

Related biology news :

1. ISNs Nexus Hypertension-Kidney debate
2. Penn researchers awarded $1.1 million for Pulmonary Hypertension Center
3. Hypertension risk in African-Americans linked to genetics, Stanford study finds
4. Clues to future evolution of HIV come from African green monkeys
5. First all-African produced genetically engineered maize is resistant to maize streak virus
6. New clue why MS affects African-Americans differently than Caucasians
7. Stressed-out African naked mole-rats may provide clues about human infertility
8. Slow wave activity during sleep is lower in African-Americans than Caucasians
9. OSA symptoms more common among African-American women than Caucasians
10. West African Ocean sediment core links monsoons to global climate evolution
11. African carnage -- 1 years seized ivory likely came from 23,000 elephants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hypertension African Americans linked two genomic regions

(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
(Date:3/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces its ... of the products featured in 2015 "I Want That" ... PM EST on the DIY Network.   ... Vegas , site of the 2015 International CES ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
(Date:3/27/2015)... The consumption of compound fertilizers (NPK) fertilizers ... high prices in 2008. However, the situation has stabilised ... gaining momentum now. , To date, the world annual ... thousand tonnes. No considerable growth was registered in the ... during 2012-2013, registering 11% growth as against the period ...
(Date:3/27/2015)... Mich. , March 27, 2015  Neogen Corporation ... LLC, has adopted a prearranged trading plan in accordance ... Herbert , Chairman and CEO of Neogen Corporation, is ... of Neogen Corporation common stock. Herbert does ... disclosure was appropriate. The filing is only for a ...
(Date:3/27/2015)... 2015  Peter Walter was chosen as winner of ... work on how proteins are transported between cellular compartments ... that cells use to handle stress tied to the ... of biochemistry at the University of California, San Francisco. ... of human diseases related to defective protein folding and ...
(Date:3/27/2015)... , March 27, 2015 WuXi ... leading open-access R&D capability and technology platform company ... industries, announced today that an Investigational New Drug ... antibody for rheumatoid arthritis has been accepted for ... (CFDA).  In September 2012, MedImmune, ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3Neogen CEO adopts 10b5-1 Trading Plan 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3
Cached News: